Abiopharma

🔍 Bone Jane E (Executive)

Company: Elastic N.V. (ESTC)

Report Date: 2026-06-08

Detailed Transactions and Holdings:

• Acquired 12,069 shares of Ordinary Shares (Direct)
  Date: 2026-06-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 54,519.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,104 shares of Ordinary Shares at $60.61 per share (Direct)
  Date: 2026-06-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 53,415.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: The ordinary shares are represented by restricted stock units ("RSUs"), which vest in sixteen equal quarterly installments beginning on September 8, 2026.
• F2: Includes 166 ordinary shares purchased under the Issuer's Employee Stock Purchase Plan on March 15, 2026.
• F3: The ordinary shares were sold to satisfy the Reporting Person's tax obligations in connection with the vesting of RSUs. The sales were mandated by the Issuer's equity incentive plan which requires the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.